Mostrando 2 resultados de: 2
Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC
ArticleAbstract: Hepatocellular carcinoma (HCC) has very poor prognosis. Astemizole has gained great interest as a poPalabras claves:Astemizole, Eag1, Liver cancer, Liver cirrhosis, Potassium channels, tumor markersAutores:Acuña-Macías I., Caro-Sánchez C.H., Chiliquinga A.J., de Guadalupe Chávez-López M., Díaz-Chávez J., Gariglio P., Hernández-gallegos E., Herrera L.A., Javier Camacho, Pérez-Carreón J.I., Zúñiga-García V.Fuentes:scopusLiver cancer analysis using bioimpedance
Conference ObjectAbstract: In this work the impedance analysis is used in order to determinate differences between tumor and unPalabras claves:Electrical impedance measurement, FFT and cross-correlation, Liver cancer, Phase angleAutores:Chávez-lópez M.d.G., Elías D., Javier Camacho, Salazar-Anguiano J., Zúñiga-García V.Fuentes:scopus